Category Matches
- 0.1 mg
- 1 g
- 1 kg
- 1 kit
- 1 L
- 1 mg
- 1 ml
- 1 MU
- 1 Plate
- 1 µg
- 10 g
- 10 mg
- 10 ml
- 10 µg
- 100 g
- 100 mg
- 100 mh
- 100 ml
- 100 Tests
- 100 µg
- 100-200 Tests
- 1000 g
- 100g
- 11β-HSD Inhibitor
- 125 mg
- 125 Tests
- 1mg
- 2 mg
- 2 Plates
- 2-BHA
- 2-Deoxy-D-Glucose
- 2-deoxy-D-glucose
- 2-DG
- 2.5 mg
- 20 g
- 20 mg
- 20 Tests
- 200 Tests
- 200 µg
- 24 Tests
- 25 g
- 25 mg
- 25 ml
- 25 Tests
- 25 µg
- 25-250 Tests
- 25-50 Tests
- 250 g
- 250 mg
- 250 ml
- 250 Tests
- 250 µg
- 250mg
- 25g
- 25mg
- 2BHA
- 5 x 100 µg
- 5-a-reductase Inhibitors
- 5-bromo-2'-deoxyuridine
- 5-HT1 Receptors - Analgesics
- 5-HT1 Receptors - Antidepressant
- 5-HT1 Receptors - Antipsychotic
- 5-HT1 Receptors - Anxiolytic
- 5-HT1 Receptors - Cognition Enhancing
- 5-HT1 Receptors - Hypnotics
- 5-HT1 Receptors - Sedatives
- 5-HT2 Receptors - Analgesics
- 5-HT2 Receptors - Antidepressant
- 5-HT2 Receptors - Antipsychotic
- 5-HT2 Receptors - Anxiolytic
- 5-HT2 Receptors - Cognition Enhancing
- 5-HT2 Receptors - Hypnotics
- 5-HT2 Receptors - Neurodegenerative Diseases
- 5-HT2 Receptors - Sedatives
- 5-Lipoxygenase Inhibitors
- 5-α-Reductase Inhibitors
- 50-100 Tests
- a-Glucosidase Inhibitors
- ACE Inhibitors
- ACP-196
- ACP196
- adu-s100
- adus100
- AMG-925
- Androgen Synthesis Inhibitors
- Angiotensin II Inhibitors
- Aromatase Inhibitors - Anticancer
- Aromatase Inhibitors - Immunology
- arv825
- AT-7519
- AT7519
- AZ-5104
- AZ5104
- AZD-1152
- AZD-1152-HQPA
- AZD-1208
- AZD-8186
- AZD-9291
- B02
- BACE1
- BAY1816032
- Bcl-2
- BIX01294
- BML-275
- BUB1
- BYL719
- Ca2+ Channel Blockers - Anti-anginal
- Ca2+ Channel Blockers - Antihypertensive
- Ca2+ Channel Blockers - Vasodilatory
- Ca2+ Channels - Analgesics
- Ca2+ Channels - Anesthetic
- Ca2+ Channels - Antidepressant
- Ca2+ Channels - Antiepileptics and Anticonvulsants
- Ca2+ Channels - Antipsychotic
- Ca2+ Channels - Anxiolytic
- Ca2+ Channels - Cognition Enhancing
- Ca2+ Channels - Sedatives
- Ca2+ Ion Channels - Neurodegenerative Diseases
- Ca2+-sensing Receptors - Neurodegenerative Diseases
- CCK Release Inhibitors
- CCT-245737
- CEP-28122
- chemicals for COVID-19 research
- CHIR99021
- Chk1/2
- Class IV (Ca2+ Channel Blocker)
- COVID-19
- covid-19
- COVID-19 chemicals
- COVID-19 compounds
- COX - Analgesics
- COX-1 - Analgesics
- COX-2
- COX-2 - Analgesics
- Coxibs
- CPI-203
- CYP17A1 Inhibitors
- D1 Receptors - Analgesics
- D1 Receptors - Anesthetic
- D1 Receptors - Antidepressant
- D1 Receptors - Antipsychotic
- D1 Receptors - Anxiolytic
- D1 Receptors - Cognition Enhancing
- D1 Receptors - Neurodegenerative Diseases
- D1 Receptors - Sedatives
- D2 Receptor Antagonists
- D2 Receptors - Analgesics
- D2 Receptors - Anesthetic
- D2 Receptors - Antidepressant
- D2 Receptors - Antipsychotic
- D2 Receptors - Anxiolytic
- D2 Receptors - Cognition Enhancing
- D2 Receptors - Neurodegenerative Diseases
- D2 Receptors - Sedatives
- Dihydrofolate Reductase Inhibitors
- DNA and RNA Synthesis Inhibitors
- Dopamine Receptor Inhibitors
- DOT1L Histone Methyltransferase
- DPP-4 Inhibitors
- Eicosanoid Inhibitors
- eidd-1931
- EIDD-2801
- EIDD2801
- eIF2B - Cognition Enhancing
- eIF2B - Neurodegenerative Diseases
- Ergosterol Inhibitors
- Estrogen Receptor Inhibitors
- EZH2 Histone Methyltransferase
- Factor Xa Inhibitors
- Furans - Other nucleic acid inhibitors
- GBR-12935
- GDC-0032
- GDC-0941
- GLP-1 Agonists
- GSK-429286A
- HEXIM1
- HIF-1
- HMG-CoA Reductase Inhibitors (Statins)
- Hs578T
- Hs578Ts(i)8
- IGF-1R
- Indoleamine 2,3-dioxygenase
- Inhibitors of other enzymes
- Integrase Inhibitors
- ITF-2357
- JQ-1
- JQ-1
- K252a
- K252b
- K252c
- Kinesin Inhibitors
- KNL1
- LMK-235
- lmk235
- LOXO-195
- loxo195
- LRRK2 - Neurodegenerative Diseases
- lx2343
- LY-2606368
- LY2606368
- M2 Protein Inhibitors
- MDM2
- Microtubule Polymerization/Depolymerization Inhibitors
- Muscarininc Acetylcholine Receptor Inhibitors
- NCCT Inhibitors (Thiazide/Thiazide-like diuretics)
- Neuraminidase Inhibitors
- NKCC1 Inhibitors (Loop Diuretics)
- NMS-E628
- NSAIDs: COX-1 Inhibitors
- NSAIDs: COX-2 Inhibitors
- nu2058
- Other Nucleic Acid Inhibitors
- Others - Ergosterol Inhibitors
- Others - Other nucleic acid inhibitors
- OTX-015
- p110
- p110alpha
- P2Y12
- PDK1
- PF-07321332
- PIK-294
- Pim-1
- Pim1
- PKC412
- Prostaglandin D Synthase Inhibitors
- Protease Inhibitors
- Protein synthesis Inhibitors
- Proton Pump Inhibitors
- Rac1
- RAD51
- rated-1
- rated-2
- Renin Inhibitors
- Reverse Transcriptase Inhibitors
- RN-1734
- ROS1
- SARS-CoV-2
- SARS-CoV2
- SB-203580
- SB-431542
- ser910
- Serine/Threonine Kinase Inhibitors
- Serotonin (5-HT3) Receptor Inhibitors
- SNS-032
- su5402
- su9516
- T315i
- TAK-931
- Thrombin Inhibitors
- Topoisomerase Inhibitors
- Tubulin Inhibitors
- Tyrosine Kinase Inhibitors
- UNC0064-12
- VE821
- VE822
- Viral Fusion and Entry Inhibitors
- XL-228
- α1-adrenergic Receptor Antagonists - Antihypertensive
- α1-adrenergic Receptor Antagonists - Vasodilatory
- α2-adrenergic Receptor Agonists
- β-Glucan Synthase Inhibitors (echinocandins)
- β-lactamase inhibitors
Product Matches
- I524086Incensol
Component of Frankincense resin.
≥98% - I524088Incensol Acetate
Component of Frankincense resin.
≥98% - M1847704-O-Methylhonokiol
Found in Magnolia officinalis.
≥98% - D3322Diflunisal
NSAID; COX-1/2 inhibitor.
≥98% - S0048Salicin
Alcoholic β-glucoside found in willow bark, salicylic acid prodrug; serine p...
≥98% - S1612Sedanolide
Phthalide found in celery seeds; COX-1, COX-2, topoisomerase I, topoisomerase...
≥98% - K1677Ketoprofen
NSAID; COX-1/2 and lactate dehydrogenase inhibitor.
≥98% - S0244Salsalate
Salicylic acid prodrug, NSAID; weak COX-1/2 inhibitor.
≥95% - F1655Fenoprofen Calcium Dihydrate
NSAID; COX-1/2 inhibitor.
≥97% - L5870Lornoxicam
NSAID; COX-1/2 inhibitor.
≥98% - F1652Fenbufen
NSAID; COX-1/2 inhibitor.
≥98% - I5315Indomethacin
NSAID; COX-1/2 inhibitor.
≥98% - I0481Ibuprofen
NSAID; COX-1/2 inhibitor.
≥98% - A0816Acemetacin
Glycolic acid ester prodrug of indomethacin, NSAID; COX-1/2 inhibitor.
≥98% - O4672Olsalazine Sodium
5-Aminosalicylate prodrug, NSAID; COX-1/2 inhibitor.
≥98% - F4481Flurbiprofen
NSAID; COX-1/2 inhibitor.
≥98% - L5993Loxoprofen Sodium Dihydrate
NSAID; COX-1/2 inhibitor.
≥98% - I7074Irsogladine Maleate
NSAID; COX-1/2 and PDE inhibitor.
≥98% - A5161Ampiroxicam
Piroxicam prodrug, NSAID; COX-1/2 inhibitor.
≥98% - S8147Sulindac Sulfide
NSAID; COX-1/2 and PDE inhibitor.
≥98%